C19ORF52 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.56328291925456E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.08066938415186E-12 |
Normal-vs-Stage2 |
4.44560000001371E-06 |
Normal-vs-Stage3 |
6.68179955809478E-10 |
Normal-vs-Stage4 |
2.968100E-04 |
Stage1-vs-Stage2 |
7.588200E-01 |
Stage1-vs-Stage3 |
7.640400E-01 |
Stage1-vs-Stage4 |
1.466180E-02 |
Stage2-vs-Stage3 |
6.314400E-01 |
Stage2-vs-Stage4 |
1.457390E-01 |
Stage3-vs-Stage4 |
1.749670E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.69075864420165E-12 |
Normal-vs-AfricanAmerican |
7.766100E-02 |
Normal-vs-Asian |
1.186240E-01 |
Caucasian-vs-AfricanAmerican |
3.93929999997766E-06 |
Caucasian-vs-Asian |
3.511800E-01 |
AfricanAmerican-vs-Asian |
4.126600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.76840789076505E-13 |
Normal-vs-Female |
1.47259999971894E-07 |
Male-vs-Female |
4.183700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.780800E-03 |
Normal-vs-Age(41-60Yrs) |
2.16839990407891E-10 |
Normal-vs-Age(61-80Yrs) |
7.84909914841592E-11 |
Normal-vs-Age(81-100Yrs) |
2.20859999999767E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.815800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.408200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.574400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.828000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.960800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.848800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.945400E-01 |
Normal-vs-Grade 2 |
3.68209907009032E-11 |
Normal-vs-Grade 3 |
3.60609997418493E-09 |
Normal-vs-Grade 4 |
4.30670000000077E-05 |
Grade 1-vs-Grade 2 |
1.712160E-02 |
Grade 1-vs-Grade 3 |
1.186230E-02 |
Grade 1-vs-Grade 4 |
1.285230E-01 |
Grade 2-vs-Grade 3 |
9.847400E-01 |
Grade 2-vs-Grade 4 |
2.408400E-01 |
Grade 3-vs-Grade 4 |
2.657600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.94779780982435E-11 |
Normal-vs-ccB subtype |
1.16410003858647E-09 |
ccA subtype-vs-ccB subtype |
3.521200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.53100010236562E-10 |
Normal-vs-N1 |
3.258000E-01 |
N0-vs-N1 |
3.312000E-02 |
|
|